deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT02589691

Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX) (ROC-HYPOX)

Addition of Neuromuscular-Blocking Agents During Sevoflurane Induction in Infants : Potential Interest in Reducing Hypoxemia Episodes

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Conditions Hypoxemia
Interventions Rocuronium Sodium chloride 0.9%
Updated 17 times since 2017 Last updated: Jul 17, 2023 Started: Dec 23, 2015 Primary completion: Dec 23, 2024 Completion: Dec 23, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypoxemia, this trial is ongoing. The trial is conducted by Fondation Ophtalmologique Adolphe de Rothschild and has accumulated 17 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshot~Sep 2017 – ~Mar 2018 · 6 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Jan 2020 · 5 months · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Apr 2023 · 14 months · monthly snapshot~Apr 2023 – ~Aug 2023 · 4 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshot

Change History

17 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown PHASE4

    Status: Recruiting → Unknown

  2. Sep 2024 — Jan 2026 [monthly]

    Recruiting PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

  4. Aug 2023 — Jul 2024 [monthly]

    Recruiting PHASE4

  5. Apr 2023 — Aug 2023 [monthly]

    Recruiting PHASE4

▶ Show 12 earlier versions

  1. Feb 2022 — Apr 2023 [monthly]

    Recruiting PHASE4

  2. Sep 2021 — Feb 2022 [monthly]

    Recruiting PHASE4

  3. Apr 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  4. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE4

  5. Jan 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  6. Aug 2019 — Jan 2020 [monthly]

    Recruiting PHASE4

  7. Feb 2019 — Aug 2019 [monthly]

    Recruiting PHASE4

  8. Sep 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  9. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE4

  10. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  11. Sep 2017 — Mar 2018 [monthly]

    Recruiting PHASE4

  12. Jan 2017 — Sep 2017 [monthly]

    Recruiting PHASE4

    First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondation Ophtalmologique Adolphe de Rothschild
Data source: Fondation Ophtalmologique Adolphe de Rothschild

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations